“…Such materials can be used effectively in the purification of synthetic peptides in order to meet FDA purity expectations. Thus, in order to complement traditionally employed alkyl (generally C 8 , C 18 groups 1, 2) functional groups, developments in silica surface modification over the past two decades or so have included polar‐embedded phases 3–37, polar‐endcapped phases 15, 21, 23, 26, 28, 31–34 and phases containing phenyl groups 26, 31, 38–46, all with intent of providing alternate selectivity.…”